Not available
Quote | Co-Diagnostics Inc. (NASDAQ:CODX)
Last: | $1.25 |
---|---|
Change Percent: | 0.78% |
Open: | $1.27 |
Close: | $1.25 |
High: | $1.31 |
Low: | $1.22 |
Volume: | 83,603 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Co-Diagnostics Inc. (NASDAQ:CODX)
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 PR Newswire SALT LAKE CITY , June 18, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented plat...
Message Board Posts | Co-Diagnostics Inc. (NASDAQ:CODX)
Subject | By | Source | When |
---|---|---|---|
May 1 short volumes: $CODX 47%, FLGT 46%, | Schrodingers Cat | investorshub | 05/02/2023 1:36:06 AM |
Apr 28 short volumes: $CODX 26%, FLGT 50%, | Schrodingers Cat | investorshub | 04/29/2023 1:52:54 AM |
Apr 27 short volumes: $CODX 38%, FLGT 49%, | Schrodingers Cat | investorshub | 04/28/2023 12:41:29 AM |
Apr 26 short volumes: $CODX 25%, FLGT 53%, | Schrodingers Cat | investorshub | 04/27/2023 12:34:12 AM |
Apr 25 short volumes: $CODX 23%, FLGT 53%, | Schrodingers Cat | investorshub | 04/26/2023 12:59:44 AM |
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 PR Newswire SALT LAKE CITY , June 18, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented plat...
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform PR Newswire The Company expects that the application for OTC clearance will shortly be followed by pursuit of POC clearance, with other tests in the pipeline to meet the needs of a global ma...